Design Therapeutics, Inc. - Common Stock — 四半期キャッシュフロー (NASDAQ:DSGN) | MetaTrader

チャート全体を表示 Full chart

Financials

概要明細書統計

総資産 252.09 M237.47 M222.89 M211.77 M226.2 M230.44 M 負債合計 10 M9.56 M9.85 M12.05 M13.7 M12.39 M 純資産合計 242.1 M227.92 M213.04 M199.72 M212.5 M218.05 M 負債および純資産合計 252.09 M237.47 M222.89 M211.77 M226.2 M230.44 M 有利子負債合計 —————— 純負債 ——————

ニュース

FDA Extends Review Time for AZN's Camizestrant Combo in Breast Cancer

AZN, Daiichi's Datroway Wins FDA Nod for Expanded Use in Breast Cancer

Design Therapeutics Stock Wobbles After Rare Genetic Disease Data - Design Therapeutics (NASDAQ:DSGN)

Design Therapeutics, Inc. (DSGN) Discusses Data from RESTORE-FA Trial of DT-216P2 for Friedreich Ataxia Transcript

This Biotech Leader Ran Up As Much As 18% — And Then Lost It All

Cramer: Design Therapeutics Is ‘Pure Spec,’ Buy This Health Care Stock - BillionToOne (NASDAQ:BLLN), Desi

Design Therapeutics, Inc. (DSGN) Is Up 6.92% in One Week: What You Should Know

Design Therapeutics, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:DSGN) 2026-04-30

Design Therapeutics, Inc. (DSGN) Q1 2026 Earnings Call Prepared Remarks Transcript

Jefferies、医薬品の潜在力を評価しDesign Therapeutics株をバイで開始

Jefferies initiates Design Therapeutics stock with buy on drug potential

RBC Capital、プログラム進展を受けてDesign Therapeuticsの目標株価を引き上げ